Online auction: Laboratory, R&D and analytical equipment from Merck, Eli Lilly, Teva and leading global firms

Published: 22-Jun-2018
Manufacturing

Featuring HPLCs, mass spectrometers, bioreactors and much more

You may also like

Manufacturing

Merck buys WuXi Biologics' Irish vaccine manufacturing facility for $500m

Read more
This sale is part of WuXi Biologics' initiative to build business in the face of the BIOSECURE act, as the company places a stronger focus on building its CDMO services in China

Trending Articles

  1. ReciBioPharm attains Bill & Melinda Gates Foundation grant to achieve continuous RNA manufacturing The biologics CDMO hopes to bring RNA medicines to more patients globally by providing its xRNA continuous manufacturing technology to lower and middle income countries
  2. Arterex completes acquisition of medical device manufacturer Phoenix The medical device specialist will have access to Phoenix's Modena facility, which has four ISO 8 cleanrooms for sterile assembly and packaging and 37,000 sqft of manufacturing space
  3. Sartorius and McMaster University inaugurate new Ontario bioprocessing automation lab The lab will unite students, Sartorius employees and other industry partners in exploring modelling and predictive control solutions for accelerated biomanufacturing
  4. Manufacturing Chemist Stand Side with Quotient Sciences We discover what exhibitors at CPHI Milan 2024 are showcasing LIVE!
  5. Finalists of the 2025 Pharmapack awards named The awards will honour innovators in the drug delivery and packaging industries, as well as unique start-ups that are shaping the pharmaceutical scene

Upcoming event

Pharma Packaging and Labelling Forum

5–6 March 2025 | Conference | San Diego, US See all

You may also like

Manufacturing

Merck buys WuXi Biologics' Irish vaccine manufacturing facility for $500m

This sale is part of WuXi Biologics' initiative to build business in the face of the BIOSECURE act, as the company places a stronger focus on building its CDMO services in China
Manufacturing

Merck bolsters its ADC CDMO offering with €71m Missouri manufacturing site expansion

The facility's expansion has tripled its ADC manufacturing capacity, bolstering Merck's CDMO offering for current and new clients
Manufacturing

Eli Lilly's Irish synthetic peptide manufacturing facility bags an ISPE FOYA award

The award celebrates Lilly's incorporation of advanced technologies into the peptide manufacturing process
Manufacturing

Merck launches single-use reactor designed to accelerate antibody drug conjugate manufacturing

First scalable single-use mixer specifically designed for ADC manufacturing. It increases efficiency by 70% compared to stainless steel or glass manufacturing methods and utilises Ultimus® Film for superior leak resistance
Manufacturing

Merck and Daiichi Sankyo expand antibody drug conjugate commercialisation agreement

The companies will collaborate to commercialise MK-6070, a T-cell engager which has shown promise in treating patients with small cell lung cancer (SCLC)
Manufacturing

Europe’s generic medicines are disappearing, study finds

Over a ten year period, the number of generic medicines withdrawn from the market increased by 12%
Manufacturing

Merck expands newest biologics testing centre in Shanghai

New labs complete the second phase of the company’s €29m biologics testing centre, which was opened in 2022
Subscribe now